Tonix Pharmaceuticals reports positive topline trial outcomes of TNX-1500
Tonix Pharmaceuticals has reported positive topline outcomes from its Phase I single ascending dose study of its ...
Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash
Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first ...
Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash
Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of 2026 Company is debt-free after repaying mortgage on facilities ...
Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer
Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product DevelopmentTonix is Preparing for Potential Launch ...
Tonix Pharmaceuticals trading halted, news pending
EST Tonix Pharmaceuticals (TNXP) trading halted, news pendingMaximize Your Portfolio with Data Driven Insights:Leverage the power of ...
American Association of Individual Investors4d
Why Tonix Pharmaceuticals Holding Corp.’s (TNXP) Stock Is Down 54.47%
Tonix Pharmaceuticals Holding Corp.’s TNXP share price has dipped by 54.47%, which has investors questioning if this is right ...
Investornewsbreaks Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Promotes Siobhan Fogarty To Chief Technical Officer
Tonix Pharmaceuticals (NASDAQ: TNXP) announced the promotion of Siobhan Fogarty to chief technical officer. Fogarty, who joined Tonix in 2016, previo ...
Hosted on MSN1d
Tonix Pharma Dominates Retail Biotech Buzz After 1-for-100 Reverse Split, Sentiment Turns Neutral Amid Volatility
Tonix Pharmaceuticals saw its shares swing wildly between gains and losses on Wednesday morning as they started to trade ...
Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer
Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product Development Tonix is Preparing for Potential Launch of TNX-102 SL for the management of fibromyalgia with ...
ETF Daily News5d
Tonix Pharmaceuticals (NASDAQ:TNXP) vs. Annexon (NASDAQ:ANNX) Head-To-Head Contrast
Tonix Pharmaceuticals has a beta of 2.02, meaning that its share price is 102% more volatile than the S&P 500. Comparatively, Annexon has a beta of 1.11, meaning that its share price is 11% more ...